Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value: $566M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MYOKARDIA INC | 1,071,889 | $45.93M | 8.1% | $17.38 | — | COM | 62857M105 |
| — | IGNYTA INC | 3,500,000 | $43.23M | 7.6% | $11.49 | — | COM | 451731103 |
| OMER | OMEROS CORP | 1,700,000 | $36.75M | 6.5% | $17.26 | +22.8% | COM | 682143102 |
| ANAB | ANAPTYSBIO INC | 1,000,000 | $34.95M | 6.2% | $24.05 | +12.2% | COM | 032724106 |
| TBPH | THERAVANCE BIOPHARMA INC | 950,000 | $32.53M | 5.7% | $23.62 | +38.4% | COM | G8807B106 |
| — | PORTOLA PHARMACEUTICALS INC | 500,000 | $27.02M | 4.8% | $36.11 | — | COM | 737010108 |
| — | G1 THERAPEUTICS, INC. | 897,505 | $22.34M | 3.9% | $20.91 | — | COM | 3621LQ109 |
| — | BLUEBIRD BIO INC | 137,500 | $18.89M | 3.3% | $105.05 | — | COM | 09609G100 |
| — | QUOTIENT LTD | 3,485,921 | $17.19M | 3.0% | $10.34 | — | SHS | G73268107 |
| — | CLEARSIDE BIOMEDICAL INC | 1,940,880 | $16.96M | 3.0% | $7.30 | — | COM | 185063104 |
| — | JUNO THERAPEUTICS INC | 375,000 | $16.82M | 3.0% | $23.22 | — | COM | 48205A109 |
| — | OMEROS CORP | 750,000 | $16.21M | 2.9% | $21.62 | — | CALL | 682143902 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 250,000 | $15.32M | 2.7% | $15.30 | +245.0% | COM | 64125C109 |
| ACRS | ACLARIS THERAPEUTICS INC | 550,000 | $14.2M | 2.5% | $19.94 | +34.4% | COM | 00461U105 |
| — | REATA PHARMACEUTICALS INC | 388,574 | $12.09M | 2.1% | $31.10 | — | CL A | 75615P103 |
| EGRX | EAGLE PHARMACEUTICALS INC | 200,000 | $11.93M | 2.1% | $40.56 | +49.1% | COM | 269796108 |
| — | MIRATI THERAPEUTICS INC | 1,000,000 | $11.7M | 2.1% | $11.70 | — | COM | 60468T105 |
| — | ARRAY BIOPHARMA INC | 900,000 | $11.07M | 2.0% | $6.75 | — | COM | 04269X105 |
| — | ALDER BIOPHARMACEUTICALS INC | 900,000 | $11.03M | 1.9% | $32.02 | — | COM | 014339105 |
| HRTX | HERON THERAPEUTICS INC | 570,000 | $9.206M | 1.6% | $15.72 | -0.2% | COM | 427746102 |
| — | NEVRO CORP | 100,000 | $9.088M | 1.6% | $57.41 | — | COM | 64157F103 |
| — | AUDENTES THERAPEUTICS INC | 323,545 | $9.062M | 1.6% | $17.81 | — | COM | 05070R104 |
| ZLAB | ZAI LABS LTD | 333,166 | $8.995M | 1.6% | $27.00 | — | ADR | 98887Q104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 500,000 | $8.835M | 1.6% | $13.67 | +1.3% | COM | 74366E102 |
| — | PROTEOSTASIS THERAPEUTICS IN | 3,804,027 | $7.988M | 1.4% | $12.20 | — | COM | 74373B109 |
| — | GEMPHIRE THERAPEUTICS INC | 800,000 | $7.552M | 1.3% | $10.90 | — | COM | 36870A108 |
| — | INTEC PHARMA LTD JERUSALEM | 809,804 | $7.248M | 1.3% | $5.59 | — | SHS | M53644106 |
| — | ABEONA THERAPEUTICS INC | 400,000 | $6.82M | 1.2% | $4.85 | — | COM | 00289Y107 |
| SGMO | SANGAMO THERAPEUTICS INC | 400,000 | $6M | 1.1% | $6.37 | +73.5% | COM | 800677106 |
| — | JOUNCE THERAPEUTICS INC | 359,738 | $5.605M | 1.0% | $21.99 | — | COM | 481116101 |
| — | AGILE THERAPEUTICS INC | 1,250,000 | $5.575M | 1.0% | $4.95 | — | COM | 00847L100 |
| — | BLUEPRINT MEDICINES CORP | 75,000 | $5.225M | 0.9% | $27.50 | — | COM | 09627Y109 |
| — | MERSANA THERAPEUTICS | 295,549 | $5.11M | 0.9% | $16.39 | — | COM | 59045L106 |
| — | ADVANCED ACCELERATOR APPLIC | 75,000 | $5.072M | 0.9% | $26.76 | — | SPONSORED ADS | 00790T100 |
| — | MINERVA NEUROSCIENCES INC | 607,903 | $4.62M | 0.8% | $7.26 | — | COM | 603380106 |
| WVE | WAVE LIFE SCIENCES LTD | 202,079 | $4.395M | 0.8% | $17.46 | +15.1% | SHS | Y95308105 |
| — | SYROS PHARMACEUTICALS INC | 296,296 | $4.361M | 0.8% | $16.09 | — | COM | 87184Q107 |
| — | CYMABAY THERAPEUTICS INC | 500,000 | $4.03M | 0.7% | $8.06 | — | COM | 23257D103 |
| — | CONTRAFECT CORP | 3,550,000 | $3.941M | 0.7% | $2.80 | — | COM | 212326102 |
| ARDX | ARDELYX INC | 572,738 | $3.207M | 0.6% | $15.57 | -66.2% | COM | 039697107 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 300,000 | $3.147M | 0.6% | $17.28 | -36.2% | COM | 19459J104 |
| — | TRILLIUM THERAPEUTICS INC | 600,000 | $3.09M | 0.5% | $4.40 | — | COM NEW | 89620X506 |
| — | IMMUNE DESIGN CORP | 280,500 | $2.903M | 0.5% | $12.79 | — | COM | 45252L103 |
| — | ACCELERON PHARMA INC | 75,000 | $2.799M | 0.5% | $32.04 | — | COM | 00434H108 |
| OVID | OVID THERAPEUTICS INC. | 223,972 | $1.919M | 0.3% | $13.06 | -36.2% | COM | 690469101 |
| CTMX | CYTOMX THERAPEUTICS INC | 100,000 | $1.817M | 0.3% | $15.82 | -1.4% | COM | 23284F105 |
| — | CURIS INC | 1,150,000 | $1.714M | 0.3% | $2.44 | — | COM | 231269101 |
| — | ONCOBIOLOGICS INC | 593,883 | $814K | 0.1% | $3.28 | — | COM | 68235M105 |
| — | ONCOBIOLOGICS INC | 416,666 | $51,000 | 0.0% | $0.46 | — | *W EXP 02/18/201 | 68235M113 |
| — | ONCOBIOLOGICS INC | 416,666 | $21,000 | 0.0% | $0.45 | — | *W EXP 05/18/201 | 68235M121 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $8,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |